Your session is about to expire
← Back to Search
Probiotic
Probiotics and the Microbiome: Clinical Intervention Trial for Anxiety and Depression
Phase 2
Waitlist Available
Led By Dr. Susan Potter, PhD
Research Sponsored by Acadia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up administered at 10 weeks
Summary
The proposed project will investigate the effects of probiotics on anxiety and associated psychological and physiological factors in humans. The therapeutic potential of probiotics for reducing anxiety and other factors associated with a disrupted microbiome will be assessed in a double-blind placebo-crossover design. Based on the research findings to date, it is hypothesized that probiotics will reduce anxiety and depressive symptoms.
Eligible Conditions
- Depression
- Botox
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (at first meeting)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (at first meeting)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Anxiety Sensitivity Index (ASI) - Time 1 (we are assessing change over time)
Anxiety Sensitivity Index (ASI) - Time 2 (we are assessing change over time)
Anxiety Sensitivity Index (ASI) - Time 3 (we are assessing change over time)
+3 moreTrial Design
2Treatment groups
Active Control
Placebo Group
Group I: ProbioticsActive Control1 Intervention
400mg probiotic capsule taken once daily for ten weeks
Group II: Placebo (rice flour)Placebo Group1 Intervention
400mg placebo capsule containing rice flour taken once daily for ten weeks
Find a Location
Who is running the clinical trial?
Acadia UniversityLead Sponsor
2 Previous Clinical Trials
150 Total Patients Enrolled
Dr. Susan Potter, PhDPrincipal InvestigatorAcadia University